4^th International Conference on Hypertension & Healthcare planned to be held in the beautiful Zurich City, Switzerland which is small but well know country in the heart of Europe during September 10-11, 2018.

Working under the theme “Control Hypertension: Add life to Longevity” we bring together a unique international mix of large and medium medical and clinical research and diagnostic companies, leading universities and medical research institutions. This is a perfect platform to share experience, foster collaborations across industry and academia and evaluate emerging innovations around the world. This conference mainly focuses on spreading the awareness about challenges in this field and how to prevent and manage hypertension and other cardiovascular diseases. 

Why to attend?? 

Encounter the target market with members from across the globe, committed to learn about hypertension treatment and management. This is the best opportunity to outreach the largest gathering of participants from around the world. Conduct presentations, distribute and update knowledge about the current situation of hypertension treatment and receive name recognition at this 3-days event. World-eminent speakers, most recent researches, latest treatment techniques and the advanced updates in Hypertension Management are the principal features of this conference.

Target Audience:

Our Organization would be privileged to welcome the:

• Directors of Hypertension or related Programs or Associations
• Heads, Deans and Professors of Hypertension or Cardiology departments
• Scientists and Researchers organizers
• Doctors
• Medical Colleges
• Writers
• Healthcare professionals
• Founders and Employees of the related companies
• Clinical investigators
• Hospitals and Health Services
• Pharmaceutical companies
• Laboratory members
• Training institutions
• Support organizers
• Data Management Companies
• Cardiologists training and education
• Nurse and nursing education institutions

Sessions

Encouraged with the success of hypertension conference series, we bring up the 4^th International Conference on Hypertension and Healthcare with its powerful 2-days agenda. Hypertension 2018 is designed to take place at the beautiful Zurich in the Switzerland during September 10-11, 2018.

Track 1: Hypertension

• Secondary hypertension
• Hypertension rheumatoid arthritis
• Pediatric hypertension
• Oncology and blood pressure
• Genetic factors and life style of high blood pressure
• Hypertension and obesity

Track 2:  High Blood Pressure and kidney Diseases

• Renal disease
• Assessment for reno vascular hypertension
• Prevalence of epidemiology
• Kidney transplantation
• Nephrology therapies
• Evidence based methodologies for renal diagnosis and management 
• Clinical administration abilities
• Hereditary factors and endocrine issue
• Care of dialysis and transplantation

Track 3:  Pulmonary Hypertension

• Classification of pulmonary hypertension
• Sign, symptoms and causes of PH
• Genetics and molecular pathology
• Pulmonary embolism
• Diagnosis by echocardiography
• Treatment and therapies.
• Asthma and allergy
• Prevalence of pulmonary hypertension               

Track 4: Gestational Hypertension

• Risk factors for Gestational Hypertension
• Pre-eclampsia and eclampsia
• Pathogenesis of pre-eclampsia
• Genetic changes and stress incontinence.
• Surgical and non-surgical conditions
• Restorative and administration of medications
• Drug treatment of gestational hypertension

Track 5: Hypertension & Stroke

• Idiopathic intracranial hypertension
• Brain RAS on blood pressure control
• Hypertensive encephalopathy
• Cerebrovascular dysfunction
• Stroke epidemiology and prevention
• Hemorrhagic stroke
• Myocardial infarction

Track 6: Hypertension and Diabetes

• Risk factors for diabetes
• Treatment and therapies.
• Diabetes and dermatology
• Destruction of the islet β-cell
• Advanced treatments for diabetes
• Herbal and alternative remedies
• Early management of obesity 

Track 7: Hypertensive Heart Disease

• Hypertension and tachycardia
• Structural heart disease
• Transient ischemic attack
• Risk factor for fatal and nonfatal cardiovascular disease 
• Cardiovascular medicine research
• New theories of diagnosis of the blood vessels
• Cardiometabolic diseases management
• Cardiac rehabilitation
• Cardiac catheterizations, and electrophysiology studies 

Track 8: Evaluation of Hypertension

• ELISA for AAAR and cardiac myosin
• Laboratory tests for the investigation
• Endocrine or hormonal regulation of BP
• Diagnostic imaging modalities
• Interventional cardiology
• Teleradiology

Track 9: Causative Factors, Risk Assessment and Complications

• Obesity and weight management
• Non-steroidal anti-inflammatory drugs
• Not being physically active and using tobacco.
• Controllable risk factors
• Uncontrollable risk factors
• Medical risk factors
• Global cardiovascular risk assessment
• Multiple risk management

Track 10:  Diagnosis and Pathophysiology of Hypertension

• Renin angiotensin aldosterone system
• Sodium /potassium ratio hypothesis of essential hypertension
• Echocardiogram
• Endoscopy
• Polysomnogram
• Endothelial dysfunction
• Vascular damage in hypertension

Track 11:  Anti- Hypertensive Medications

.

• Diuretics
• Calcium channel blockers
• ACE Inhibitors
• Angiotensin II receptor antagonists
• Benzodiazepines
• Vasodilation

Track 12: Hypertension Therapy Devices

• Blood pressure measuring devices
• Novel non-pharmacological approaches
• Baroreceptor activation therapy
• Transdermal therapy of hypertension
• Ambulatory blood pressure monitoring
• Substantial placebo effect of device therapy
• Baroreflex activation therapy
• Carotid body ablation
• Renal denervation
• Central iliac arterial-venous anastomosis
• Renal replacement therapy

Track 13: Diet and Lifestyle in Hypertension Management

• Smoking cessation
• Salt sensitivity and resistance
• Dietary potassium
• Lowering blood pressure
• Maintenance therapy and reassessment
• Resources for promoting lifestyle management to patients
• Incorporating patient-centered lifestyle modification

Track 14: Nursing Management of Hypertension

• Opportunity to assess BP detection
• Educate clients on their target BP
• Importance of achieving and maintaining target
• Frequent error in clinic-based BP assessment
• Patient preparation and posture
• Recommended technique for measuring blood pressure
• Threshold for Initiation of treatment and target values
• Assessment and development of a lifestyle treatment plan
• Impact of lifestyle therapies on BP in hypertensive
• Monitoring and follow up with the health care team
• Medications and adherence

Track 15: Advanced Treatment Approaches

• Trans catheter renal denervation
• Neprilysin /neutral end peptidase (NEP) inhibition 
• Non-viral gene therapy
• Stem cell therapy
• Invasive therapy

Track 16: Clinical Trials and Case Reports

• Integrating lifestyle advice into clinical management
• Clinical practice guidelines for the management of overweight and obesity
• Data management and statistical analysis and data validation processes
• Meta-analysis of blood pressure-lowering drug trials
• Reporting blood pressure parameters in clinical trails
• Surrogate or intermediate disease markers
• Assessment of overall cardiovascular risk in hypertensive patients
• Primary biliary cirrhosis

Track 17: Cardiologists Training and Education

• National health and medical council
• patient lifestyle modification
• Counseling and assessment with hypertension
• Monitoring antihypertensive drug treatment
• Absolute CVD risk assessment
• Clinical tuberculosis & epidemiology research
• Chronic respiratory diseases research
• Cardiac monitoring with emergency department